Nakanishi K, Ueno Y, Nakamura N, Yoshikawa H, Takeuchi T, Tanihata H, Masuda M, Terada M, Satoh M, Okamoto E
First Dept. of Surgery, Hyogo College of Medicine.
Gan To Kagaku Ryoho. 1999 Feb;26(3):353-6.
An 80-year-old woman with metastatic bone cancer from ascending colon showed a remarkable response to combination therapy of 5-FU and radiation. 5-FU (500 mg/day) was administered daily through intra-arterial catheter. The total dose of 5-FU was 15.5 g. Radiotherapy was performed (total radiation dose, 45 Gy). After therapy, metastatic lesions were remarkably reduced in size according to various imaging techniques, and the serum CEA level dramatically decreased from 249 ng/ml to 5.2 ng/ml. Other tumor markers such as CA19-9, NSE, and CYFRA were also dramatically decreased. Various tumor-related symptoms, especially the pain caused by tumor invasion, were also decreased. Drug toxicity caused slight nausea and leucopenia. These results suggested that the combination therapy of 5-FU and radiation is useful for the pain caused by metastatic bone cancer.
一名患有升结肠癌转移性骨癌的80岁女性对5-氟尿嘧啶(5-FU)与放疗的联合治疗表现出显著反应。5-FU(500毫克/天)通过动脉内导管每日给药。5-FU的总剂量为15.5克。进行了放射治疗(总辐射剂量为45 Gy)。治疗后,根据各种成像技术,转移病灶的大小显著减小,血清癌胚抗原(CEA)水平从249纳克/毫升急剧降至5.2纳克/毫升。其他肿瘤标志物,如CA19-9、神经元特异性烯醇化酶(NSE)和细胞角蛋白19片段(CYFRA)也显著下降。各种肿瘤相关症状,尤其是肿瘤侵犯引起的疼痛也有所减轻。药物毒性导致轻微恶心和白细胞减少。这些结果表明,5-FU与放疗的联合治疗对转移性骨癌引起的疼痛有效。